Evidence map›Paper›PMID 15987392›Full record

ArticleCritical care (London, England)2005

Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C.

Vladimir Kuklin, Mikhail Kirov, Mikhail Sovershaev, Thomas Andreasen, Ole C Ingebretsen, Kirsti Ytrehus, Lars Bjertnaes

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Tobacco smoking and vascular biology and function: evidence from human studies.Pflugers Archiv : European journal of physiology · 2023
    Article
  5. Review
  6. Article
  7. Endothelial Damage in Acute Respiratory Distress Syndrome.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Role of endothelin-1 in acute lung injury.Translational research : the journal of laboratory and clinical medicine · 2009
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Endothelin antagonists: new bullets against lung injury?Critical care (London, England) · 2005
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vladimir KuklinDepartment of Anesthesiology, Faculty of Medicine, University of Tromsø, Norway. Vladimir.Kuklin@unn.no
Mikhail Kirov
Mikhail Sovershaev
Thomas Andreasen
Ole C Ingebretsen
Kirsti Ytrehus
Lars Bjertnaes
UiT The Arctic University of Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionStudies in vitro reveal that endothelin-1 (ET-1) activates the alpha isoform of protein kinase C (PKC-alpha) in cultures of endothelial cells, thereby deranging cellular integrity. Sepsis and endotoxemia are associated with increased plasma concentrations of ET-1 that induce acute lung injury (ALI). We recently reported that non-selective ET-1 receptor blockade attenuates ALI in sheep by reducing the endotoxin-induced increase in extravascular lung water index (EVLWI). The aim of this study was to find out whether this attenuation is associated with reduced translocation of PKC-alpha from the cytosolic to the membrane fraction of lung tissue homogenate.

methodsSeventeen awake, instrumented sheep were randomly assigned to a sham-operated group (n = 3), a lipopolysaccharide (LPS) group (n = 7) receiving an intravenous infusion of Escherichia coli 15 ng/kg per min for 24 hours, and a tezosentan group (n = 7) subjected to LPS and, from 4 hours, an intravenous injection of tezosentan 3 mg/kg followed by infusion at 1 mg/kg per hour for the reminder of the experiment. Pulmonary micro-occlusion pressure (Pmo), EVLWI, plasma concentrations of ET-1, tumor necrosis factor-a (TNF-a), and interleukin-8 (IL-8) were determined every 4 hours. Western blotting was used to assess PKC-alpha.

resultsIn non-treated sheep a positive correlation was found between the plasma concentration of ET-1 and Pmo in the late phase of endotoxemia (12 to 24 hours). A positive correlation was also noticed between Pmo and EVLWI in the LPS and the LPS plus tezosentan groups, although the latter was significantly reduced in comparison with LPS alone. In both endotoxemic groups, plasma concentrations of ET-1, TNF-alpha, and IL-8 increased. In the LPS group, the cytosolic fraction of PKC-alpha decreased by 75% whereas the membrane fraction increased by 40% in comparison with the sham-operated animals. Tezosentan completely prevented the changes in PKC-alpha in both the cytosolic and the membrane fractions, concomitantly causing a further increase in the plasma concentrations of ET-1, TNF-alpha, and IL-8.

conclusionIn endotoxemic sheep, ET-1 receptor blockade alleviates lung injury as assessed by a decrease in EVLWI paralleled by a reduction in Pmo and the prevention of activation of PKC-alpha.

Indexed as

Endothelin A Receptor AntagonistsAnimalsEndothelin-1EndotoxemiaEnzyme ActivationEscherichia coli InfectionsInterleukin-8Protein Kinase CPyridinesRespiratory Distress SyndromeSheepTetrazolesTumor Necrosis Factor-alphaVasodilator AgentsEndothelin-1Endothelin A Receptor AntagonistsInterleukin-8Protein Kinase CPyridinesTetrazolestezosentanTumor Necrosis Factor-alphaVasodilator Agents

Identifiers

PMID15987392
PMCPMC1175881
OpenAlexW1524621166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.